Single-ascending Dose Study of Kylo-12 in Healthy Subjects
Clinical trial NCT06783881 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06783881
- Sponsor
- Kylonova (Xiamen) Biopharma co., LTD.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2025-12-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.